Puma Biotechnology PBYI
NASDAQ PBYI
$9.55 +0.14 (+1.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Puma Biotechnology (PBYI) EPS (Diluted) (2019 - 2026)

Analysis

Puma Biotechnology (PBYI) EPS (Diluted) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 12.23
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 7.15
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.33 Bn 44.33 Bn - -3.06
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.15
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.06
10 Puma Biotechnology 486.99 Mn 393.08 Mn 44.03 Mn 0.16
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.16
Mar 31, 2026 -0.07
Dec 31, 2025 0.33
Sep 30, 2025 0.17
Jun 30, 2025 0.12
Mar 31, 2025 0.06
Dec 31, 2024 0.25
Sep 30, 2024 0.41
Jun 30, 2024 -0.09
Mar 31, 2024 -0.10
Dec 31, 2023 0.26
Sep 30, 2023 0.12
Jun 30, 2023 0.05
Mar 31, 2023 0.03
Dec 31, 2022 -0.12
Sep 30, 2022 -0.01
Jun 30, 2022 0.21
Mar 31, 2022 -0.08
Dec 31, 2021 -0.45
Sep 30, 2021 -1.09